- Chronic Fatigue Syndrome:
New psychiatry research released
The latest edition of the Australian and New Zealand Journal of Psychiatry has been released and contains a number of interesting and relevant research articles including:
Association between magnesium intake and depression and anxiety in community-dwelling adults
Are chronic fatigue and chronic fatigue syndrome valid clinical entities across countries and health-care settings?
Fibromyalgia Centers of America is Now Helping Residents in Greater Chicago Area ( Near Joliet, IL)
The Nationwide Group of Doctors of Fibromyalgia Centers of America. has opened a fibromyalgia treatment center for the Greater Chicago Area at 2206 Weber Rd in Crest Hill, Illinois. Fibromyalgia Centers of America is dedicated to helping people who suffer with Fibromyalgia Syndrome and also helping those that have the same symptoms, but have not been diagnosed.
Research Finds Healthy Use For Tanning Beds As Pain Treatment
Ultraviolet light may help relieve pain in fibromyalgia syndrome patients, according to a preliminary study at Wake Forest University Baptist Medical Center conducted by dermatology, rheumatology, and public health sciences researchers.
Savella – Fibromyalgia treatment approved by FDA
Forest Laboratories, Inc. and Cypress Bioscience, Inc. have announced that Savella (milnacipran HCl), a selective serotonin and norepinephrine dual reuptake inhibitor, was approved by the U.S. Food and Drug Administration (FDA) for the management of fibromyalgia.
- Irritable Bowel Syndrome:
Syndrome amplifies pain signals to brain
Do you live with constant pain but are told that everything is normal? Do you have fibromyalgia, chronic myofascial pain, tension headache, migraine or irritable bowel syndrome and feel there is no answer in sight? You may have CSS (central sensitivity syndrome).
HK experts find Chinese medicine helps relieve irritable bowel syndrome
Chinese medicine works better than traditional western treatment in relieving irritable bowel syndrome (IBS), said a study revealed by the Chinese University of Hong Kong on Thursday. The university’s Faculty of Medicine conveyed a study more than a year ago, in which 84 patients with IBS, a common digestive disease in Hong Kong, were divided into groups receiving different treatments.